Aesthetic financing TILA compliance — APR display, promotional financing, CFPB enforcement and CareCredit, Alphaeon, PatientFi and Cherry disclosure templates
A working reference for medspa owners, aesthetic practice CFOs and marketing leads who advertise patient financing through CareCredit, Alphaeon Credit, PatientFi, Cherry, Sunbit or any other third-party lender. Written against the Truth in Lending Act, Regulation Z advertising rules at 12 CFR 1026.24, the FTC Advertising Endorsement and Substantiation standard, the CFPB's UDAAP authority under the Dodd-Frank Act, and the state usury and consumer-credit statutes that create additional overlays.
- The Truth in Lending Act at 15 USC 1601 and Regulation Z at 12 CFR 1026 apply to any advertisement or offer of consumer credit for personal purposes. A medspa advertisement of financing terms is subject to Regulation Z's advertising rules — irrespective of whether the medspa itself is the lender.
- Under 12 CFR 1026.24(d), "triggering terms" — a specific down payment, a specific number of payments, a specific payment amount, or a specific finance charge — require disclosure of all applicable additional terms with equal prominence: down payment, repayment terms, and the APR.
- Deferred-interest promotions (widely used with CareCredit and some Alphaeon Credit programs) require additional care. Clear disclosure of the promotional period, the consequences of partial payment (all deferred interest becomes payable), and the ordinary APR is mandatory. CFPB enforcement patterns in healthcare financing have concentrated here.
- Third-party financing partners — CareCredit (Synchrony), Alphaeon Credit (Comenity), PatientFi, Cherry, Sunbit — each publish practice-facing marketing kits with pre-approved copy. The kits are a floor, not a ceiling. Where practice advertising deviates from the pre-approved copy, the practice takes on the compliance burden itself.
- State usury laws, consumer-credit statutes and credit-services organization acts create additional overlays. Practices operating in multiple states should confirm whether any state-specific registration or licensing applies to the financing referral pattern.
- Dallas, Texas LLC
- US client team · Central Time (CST)
- 25+ US healthcare clients
- BAA signed with every client
- HIPAA compliance training across client and delivery teams
- Contracts and invoices in USD
-
Primary Care · North Dallas, TXCase study →
-
MedSpa · North Dallas, TX
-
Skin Care · Beverly Hills, CA
-
Dental · Christiansburg, VACase study →
-
Pediatrics · Blacksburg, VACase study →
-
Pediatric Dentistry · Blacksburg, VACase study →
-
Dental · Roanoke, VACase study →
-
Functional Medicine · Telehealth · USACase study →
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”
Why aesthetic practice financing advertising is TILA-scoped
The Truth in Lending Act was enacted in 1968 as the consumer-protection anchor for the modern credit industry. Its purpose, at 15 USC 1601, is to ensure the meaningful disclosure of credit terms so consumers can compare offers and avoid uninformed use of credit. Regulation Z at 12 CFR 1026, promulgated by the Federal Reserve and now administered by the CFPB, provides the operational rules — including the advertising rules at 12 CFR 1026.16 for open-end credit and 12 CFR 1026.24 for closed-end credit.
Regulation Z applies to advertisements about consumer credit even when the party making the advertisement is not itself the creditor. A medspa that runs a Google ad or a Facebook ad, or that publishes a landing page or a brochure, advertising a specific promotional financing offer is publishing an advertisement of consumer credit. The rules attach.
Who is a creditor
A person becomes a creditor under Regulation Z at 12 CFR 1026.2(a)(17) generally when they extend consumer credit that is subject to a finance charge or that is payable by written agreement in more than four installments, and they are the person to whom the debt is initially payable. Most medspas route financing through third-party lenders precisely to avoid becoming creditors themselves — the compliance and licensing overhead of being a creditor is substantially higher than the compliance overhead of being an advertiser of another party's credit product.
The four triggering terms that force additional TILA disclosures
Regulation Z at 12 CFR 1026.24(d)(1) lists four specific "triggering terms." If an advertisement of closed-end credit states any of them, the advertisement must also disclose the additional terms in 12 CFR 1026.24(d)(2) with equal prominence.
The triggering terms
- The amount or percentage of any down payment.
- The number of payments or period of repayment.
- The amount of any payment.
- The amount of any finance charge.
The required additional disclosures
- The amount or percentage of the down payment.
- The terms of repayment, which reflect the repayment obligations over the full term of the loan, including any balloon payment.
- The annual percentage rate, using that term or the abbreviation "APR." If the APR may be increased after consummation, the ad must state that fact.
The equal-prominence requirement is not casual. A Google ad headline reading "Botox from $99/month" — even without additional financing details — is stating a specific payment amount, which is a triggering term. The APR must appear in the same asset with equal prominence. A footnote in a smaller font is not equal prominence. An asterisk pointing to a link that discloses the APR on a subsequent page is not equal prominence.
Deferred-interest promotions — the CFPB’s central healthcare-financing concern
Deferred-interest financing is the aesthetic-vertical bread and butter. CareCredit's classic promotion is "no interest if paid in full within 6, 12, 18 or 24 months on purchases of $200 or more." Alphaeon Credit and several other healthcare-adjacent lenders offer similar structures. Deferred interest is not the same as 0% interest. In a 0% interest promotion, no interest ever accrues on the promotional balance. In a deferred-interest promotion, interest accrues from the transaction date at a stated APR but is waived if the balance is paid in full by the promotional deadline. If the balance is not paid in full, all deferred interest becomes payable.
The CFPB has taken the position, most notably in a series of consent orders in the mid-2010s and again in enforcement priorities restated more recently, that deferred-interest advertising must clearly disclose the deferred-interest consequences. Advertising that promotes "0% interest" language on a deferred-interest product without clearly explaining what happens if the balance is not paid off has been treated as deceptive under both TILA and the UDAAP prong of Dodd-Frank.
What a compliant deferred-interest disclosure looks like
- Clear labeling as "deferred interest" rather than "0% interest" or "no interest."
- Statement of the promotional period.
- Clear statement of what happens if the balance is not paid in full: "If the full amount is not paid by the end of the promotional period, interest will be charged from the transaction date."
- Disclosure of the ordinary APR that applies to the account.
- Disclosure of the minimum monthly payment and a statement that minimum payments alone will not pay off the promotional balance in time.
- Applicant-approval qualifier — "subject to credit approval" — placed with equal prominence.
Working templates for CareCredit, Alphaeon, PatientFi and Cherry
CareCredit (Synchrony)
CareCredit is the largest healthcare-financing brand in the aesthetic vertical. Synchrony publishes an approved-marketing library that gives providers pre-approved copy, badges and creative. Practice-facing compliance responsibility is highest when the practice deviates from the approved kit. The workable template for a practice landing page is:
- Headline states the option — "CareCredit financing available."
- Body states the promotional structure — "6, 12, 18 and 24-month deferred-interest financing on purchases of $200 or more, subject to credit approval."
- Body states the ordinary APR — the exact figure supplied by Synchrony in current marketing materials.
- Body states the deferred-interest consequence — "If the promotional balance is not paid in full by the end of the promotional period, interest will be charged from the transaction date at the standard APR."
- Applicant-approval qualifier — "Subject to credit approval. Minimum monthly payments required."
- Lender identification — "CareCredit is a healthcare credit card issued by Synchrony Bank."
Alphaeon Credit (Comenity)
Alphaeon Credit is Comenity's aesthetic-focused product line. Its promotional structure mirrors CareCredit in the deferred-interest and standard-APR posture. Practice landing pages should identify Alphaeon and Comenity as the issuer, disclose the promotional-period range offered, the ordinary APR, the deferred-interest structure and the credit-approval qualifier.
PatientFi
PatientFi generally offers installment loans with fixed monthly payments and a stated APR rather than deferred-interest revolving credit. The disclosure architecture is different — a fixed APR range disclosed with equal prominence, term length, and total cost of credit. Because the product is a closed-end installment loan, the 12 CFR 1026.24 triggering-term analysis applies directly.
Cherry
Cherry offers installment plans across a range of merchants including aesthetic practices. Landing pages should state the APR range (Cherry publishes tiered APR bands based on credit tier), the term options, whether any promotional 0% APR is available and its qualifying conditions, and the credit-approval qualifier. Cherry's practice-facing marketing kit provides pre-approved language; deviation shifts compliance responsibility to the practice.
The CFPB layer — UDAAP, examinations and typical enforcement patterns
The Consumer Financial Protection Bureau administers TILA on the enforcement side, and separately has authority under the Dodd-Frank Act to bring unfair, deceptive or abusive acts or practices (UDAAP) actions against covered persons and service providers. Healthcare financing has been a recurring enforcement priority since the mid-2010s and remains so.
Typical enforcement patterns have included:
- Consent orders against issuers for inadequate deferred-interest disclosures.
- Consent orders against merchants for advertising promotional terms in a way that misled consumers about the true APR or the deferred-interest consequences.
- Restitution orders returning charges to affected consumers, often in the tens of millions of dollars in aggregate.
- Civil money penalties and injunctive relief covering merchant advertising practices.
For an aesthetic practice, the exposure surface is at the intersection of Regulation Z advertising (fixed rules that produce specific per-violation exposure) and UDAAP (a broader deception-and-unfairness standard that reaches practices Regulation Z does not enumerate). Program design should satisfy both.
What we found when we studied 555 US med spas on Google
Patients praise the care almost without exception. The one area where complaints outnumber praise is booking and communication, and that is where most med spas can win.
Full study · 555 US med spas across 20 metros · roughly ±4% nationally · review velocity and themes from a 115-spa subsample · verified against raw data.
Five decisions every aesthetic practice’s financing program must make
1. Which lender partners
Two or three, not seven. Every added lender adds a distinct compliance surface. CareCredit (deferred interest revolving), Alphaeon Credit (deferred interest revolving), PatientFi (fixed-term installment), Cherry (fixed-term installment with tiered APR) cover most aesthetic use-cases.
2. Use of pre-approved kits
Base copy from each lender's kit is safest. Any deviation goes through the lender's provider-support desk for approval. No practice-invented copy on APR, deferred-interest or promotional terms.
3. Triggering-term audit
Every ad, landing page, brochure and social post that names a monthly payment, a term length, a down payment or a finance charge triggers the four Regulation Z additional disclosures. Audit for these before publish, not after.
4. Deferred-interest disclosure standard
Every deferred-interest asset labels the product as deferred interest, states the promotional period, the consequences of partial payment, the ordinary APR, and the credit-approval qualifier. Never "0% interest" for a deferred-interest product.
5. Annual kit refresh
Lenders update their approved-marketing kits when regulators press them. The practice audit checks every financing asset against the current kit annually and retires outdated versions.
State usury, consumer credit and credit-services overlays
The federal TILA/Regulation Z envelope is a floor, not a ceiling. State-level layers include:
- State usury caps. Some states impose maximum APRs on consumer loans; interstate lenders often rely on federal preemption or specific state exemptions. The relevance to a medspa is limited because the lender bears the usury exposure, not the advertiser.
- State consumer-credit statutes. Some states have their own analogues to TILA that apply additional disclosure or licensing requirements.
- Credit-services organization statutes. A handful of states regulate businesses that arrange credit for consumers. Whether these statutes reach a merchant that simply presents third-party financing to a customer varies state by state.
- State attorney general UDAP. Every state has an unfair and deceptive acts and practices statute that can be brought by the state attorney general. Aesthetic-financing advertising that misleads consumers is a live target under these statutes.
A practice operating in a single state can generally focus on federal Regulation Z plus that state's attorney general UDAP posture. A practice operating in multiple states should audit each state's specific overlay before scaling a national campaign.
Where TILA sits in the medspa marketing stack
Backed by Ichelon Consulting US leadership
Every aesthetic financing program review is conducted alongside the Leadership Team's senior US practice reviewer, with visibility into CareCredit, Alphaeon Credit, PatientFi and Cherry provider-support workflows and CFPB enforcement pattern history.
Our own tools run inside every engagement
Ichelon Consulting US uses software built by our own product team. Practices can also use most tools on their own, billed in USD.
Aesthetic financing TILA — common questions
Does the Truth in Lending Act apply to medspa financing?
Yes. TILA at 15 USC 1601 and Regulation Z at 12 CFR 1026 apply to any advertisement or offer of consumer credit for personal purposes, including a medspa ad for CareCredit, Alphaeon, PatientFi or Cherry financing.
What triggering terms activate additional TILA disclosures?
Down-payment amount or percentage, number of payments or repayment period, payment amount, or finance charge. Under 12 CFR 1026.24(d), each triggers the four required disclosures.
Do we need to disclose the APR alongside the monthly payment?
Yes. When the ad states a specific monthly payment, the APR must be disclosed with equal prominence in the same asset.
What is deferred interest and how does it affect disclosure?
Deferred interest is interest that accrues from the transaction date but is waived only if the balance is paid in full by the promotional deadline. Advertising must clearly state the consequence of partial payment, the promotional period and the ordinary APR.
What does the CFPB actually enforce?
TILA compliance and, separately, UDAAP under the Dodd-Frank Act. Typical enforcement patterns in healthcare financing target deferred-interest disclosure and merchant advertising overstatement.
Do medspas need to be licensed as a credit broker?
Generally no for a merchant that refers to a third-party lender, but some states have credit-services organization statutes that reach merchants who arrange credit. Multi-state practices should confirm state by state.
Can medspas offer their own in-house financing?
A merchant that extends credit with a finance charge or more than four installments becomes a creditor under Regulation Z. Most practices route financing through third-party lenders to avoid lender-level obligations.
What is a compliant financing landing page structure?
Product, lender, APR range, terms, deferred-interest structure and consequences if applicable, applicant-approval qualifier, effect of missed payments, and a link to the lender's full disclosure.
Do lender-provided marketing kits satisfy compliance on their own?
They are a strong floor. Deviating from the kit shifts responsibility to the practice. Run every deviation through the lender's provider-support desk for approval before publish.
How often should financing copy be audited?
Annually at minimum, and whenever the lender updates its approved-marketing kit. Retire outdated versions from the marketing library at each refresh.
Scope your TILA-compliant financing program
Book a 30-minute call with a senior member of the Leadership Team, email the US practice lead, or call the Dallas office. Retainers are custom-scoped per engagement · from $499/month, with financing copy audits priced on scope.
Continue the compliance stack
-
Primary Care · North Dallas, TXCase study →
-
MedSpa · North Dallas, TX
-
Skin Care · Beverly Hills, CA
-
Dental · Christiansburg, VACase study →
-
Pediatrics · Blacksburg, VACase study →
-
Pediatric Dentistry · Blacksburg, VACase study →
-
Dental · Roanoke, VACase study →
-
Functional Medicine · Telehealth · USACase study →
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”